The European Medicines Evaluation Agency (EMEA) has begun an investigation of Abbott Laboratories' diet drug Meridia. Italian health officials, who suspended the sale of products containing sibutramine, the primary ingredient in Meridia, after fifty "adverse events" were associated with the drug, requested the review.